230 related articles for article (PubMed ID: 33799527)
21. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
[TBL] [Abstract][Full Text] [Related]
22. Concurrent rectal perforation and obstruction following neoadjuvant chemoradiation for locally advanced rectal cancer: A case report.
Tahouri T; Hedayati Omami S; Hosseini M; Rahimi-Movaghar E
Int J Surg Case Rep; 2024 Mar; 116():109337. PubMed ID: 38310787
[TBL] [Abstract][Full Text] [Related]
23. Contemporary management of locally advanced rectal cancer: Resolving issues, controversies and shifting paradigms.
Nacion AJD; Park YY; Kim NK
Chin J Cancer Res; 2018 Feb; 30(1):131-146. PubMed ID: 29545727
[TBL] [Abstract][Full Text] [Related]
24. [Controversies and progress in adjuvant chemotherapy for patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy].
Li XX; Li QG
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):594-596. PubMed ID: 31238639
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.
Zhang J; Huang M; Cai Y; Wang L; Xiao J; Lan P; Hu H; Wu X; Ling J; Peng J; Chen D; Kang L; Zhang Y; Ren D; Wang H; Chen S; Lin F; Zheng J; Zhou Z; Wang J; Deng Y
Clin Colorectal Cancer; 2019 Dec; 18(4):238-244. PubMed ID: 31378655
[TBL] [Abstract][Full Text] [Related]
26. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
Front Oncol; 2019; 9():1196. PubMed ID: 31781498
[TBL] [Abstract][Full Text] [Related]
28. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
29. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
[TBL] [Abstract][Full Text] [Related]
30. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
32. The effect of neoadjuvant short-course radiotherapy and delayed surgery versus chemoradiation on postoperative outcomes in locally advanced rectal cancer patients - A propensity score matched nationwide audit-based study.
Hoendervangers S; Sparreboom CL; Intven MPW; Lange JF; Verkooijen HM; Doornebosch PG; van Grevenstein WMU;
Eur J Surg Oncol; 2020 Sep; 46(9):1605-1612. PubMed ID: 32192792
[TBL] [Abstract][Full Text] [Related]
33. Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
Flatmark K; Saelen MG; Hole KH; Abrahamsen TW; Fleten KG; Hektoen HH; Redalen KR; Seierstad T; Dueland S; Ree AH
Radiother Oncol; 2016 Jun; 119(3):505-11. PubMed ID: 26968754
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Inoue H; Tsutsumi H; Tanaka K; Iwama E; Shiraishi Y; Hirayama A; Nakanishi T; Ando H; Nakajima M; Shinozaki S; Ogata H; Uryu K; Okamura K; Kimura S; Ogawa T; Ota K; Yoneshima Y; Hamada N; Nakanishi Y; Okamoto I
Transl Lung Cancer Res; 2021 Jun; 10(6):2475-2486. PubMed ID: 34295655
[TBL] [Abstract][Full Text] [Related]
35. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
Schou JV; Larsen FO; Sørensen BS; Abrantes R; Boysen AK; Johansen JS; Jensen BV; Nielsen DL; Spindler KL
Ann Oncol; 2018 Mar; 29(3):610-615. PubMed ID: 29253083
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.
Uehara K; Nagino M
Surg Today; 2016 Feb; 46(2):161-8. PubMed ID: 26170102
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
38. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
39. Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Wang Y; Zhou M; Yang J; Sun X; Zou W; Zhang Z; Zhang J; Shen L; Yang L; Zhang Z
Cancer Med; 2019 Aug; 8(10):4615-4625. PubMed ID: 31250569
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study.
Yang B; Shan J; Feng Y; Dai N; Li M; Chen C; He S; Wang G; Xiao H; Li C; Wang D
Radiat Oncol; 2020 May; 15(1):94. PubMed ID: 32375814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
